Voloridge Investment Management’s AstraZeneca AZN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q1
Sell
-196,661
Closed -$12.9M 1170
2024
Q4
$12.9M Sell
196,661
-251,756
-56% -$16.5M 0.05% 502
2024
Q3
$34.9M Buy
+448,417
New +$34.9M 0.13% 247
2024
Q2
Sell
-848,793
Closed -$57.5M 1199
2024
Q1
$57.5M Buy
848,793
+597,291
+237% +$40.5M 0.21% 132
2023
Q4
$16.9M Buy
251,502
+11,308
+5% +$762K 0.07% 360
2023
Q3
$16.3M Sell
240,194
-215,422
-47% -$14.6M 0.08% 331
2023
Q2
$32.6M Sell
455,616
-460,556
-50% -$33M 0.15% 185
2023
Q1
$63.6M Buy
916,172
+47,295
+5% +$3.28M 0.32% 66
2022
Q4
$58.9M Buy
868,877
+420,967
+94% +$28.5M 0.33% 61
2022
Q3
$24.6M Buy
447,910
+444,234
+12,085% +$24.4M 0.13% 219
2022
Q2
$243K Buy
+3,676
New +$243K ﹤0.01% 1365
2022
Q1
Sell
-53,492
Closed -$3.12M 1365
2021
Q4
$3.12M Buy
+53,492
New +$3.12M 0.02% 905
2021
Q2
Sell
-1,152,052
Closed -$57.3M 1604
2021
Q1
$57.3M Sell
1,152,052
-1,933,710
-63% -$96.1M 0.42% 43
2020
Q4
$154M Buy
+3,085,762
New +$154M 1.29% 7
2020
Q3
Sell
-207,692
Closed -$11M 1246
2020
Q2
$11M Buy
207,692
+43,205
+26% +$2.29M 0.13% 174
2020
Q1
$7.35M Sell
164,487
-213,404
-56% -$9.53M 0.21% 107
2019
Q4
$18.8M Buy
377,891
+38,691
+11% +$1.93M 0.37% 49
2019
Q3
$15.1M Buy
339,200
+112,534
+50% +$5.02M 0.26% 66
2019
Q2
$9.36M Buy
226,666
+72,841
+47% +$3.01M 0.26% 84
2019
Q1
$6.22M Sell
153,825
-62,604
-29% -$2.53M 0.19% 118
2018
Q4
$8.22M Buy
+216,429
New +$8.22M 0.37% 74
2018
Q3
Sell
-245,777
Closed -$8.63M 295
2018
Q2
$8.63M Sell
245,777
-159,968
-39% -$5.62M 0.23% 103
2018
Q1
$14.2M Buy
405,745
+224,844
+124% +$7.86M 0.33% 49
2017
Q4
$6.28M Buy
+180,901
New +$6.28M 0.14% 175
2017
Q3
Sell
-315,764
Closed -$10.8M 386
2017
Q2
$10.8M Buy
+315,764
New +$10.8M 0.27% 105
2016
Q2
Sell
-655,573
Closed -$18.5M 294
2016
Q1
$18.5M Buy
+655,573
New +$18.5M 0.43% 48